DGN462 (DGN-462) is a novel and potent DNA-alkylating agent with anti-tumor activity. It has been used as a cytotoxic warhead for antibody-drug conjugates (ADCs) such as the CD19-targeting ADC huB4-DGN462, which has the potential for treating CD19-positive lymphoma and leukemia.

纯度：≥98%

CAS：1394079-41-4